Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma
NCT00582270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2023-09-21
Summary
The purpose of this study is to determine if an infectious disease may be associated with the new lymphoma diagnosis.
Infections to be tested include:
1. Helicobacter pylori (H. pylori): This is a bacteria sometimes found in the stomach that has been associated with a particular kind of lymphoma, gastric MALT. We are interested to learn if the H. pylori infection may be associated with other indolent lymphomas.
2. Hepatitis C: This virus infection of the liver has been found in association with non-follicular lymphomas in Italy. We want to determine if the infection is associated with lymphomas in the United States.
3. Bacterial overgrowth of the small bowel: Since indolent lymphomas often affect the lymph nodes surrounding the small bowel, it may be possible that an infection within the bowel is stimulating lymphoma growth. This has never been demonstrated to date, and will be studied in this clinical study.
4. Epstein-Barr virus: This is the virus that causes infectious mononucleosis or "mono." It has been associated with other rapidly growing lymphomas, but not indolent lymphoma.
Conditions
- Indolent Non-Hodgkin's Lymphoma
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Carol Portlock, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- United States
Study Locations
More Related Trials
-
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
NCT05600959 ·Status: NOT_YET_RECRUITING
-
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
NCT00154440 ·Status: UNKNOWN ·Phase: PHASE3
-
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
NCT05898477 ·Status: RECRUITING
-
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
NCT04982471 ·Status: TERMINATED
-
Quality of Life Among Survivors of Hodgkin Lymphoma
NCT00598728 ·Status: COMPLETED
-
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573 ·Status: RECRUITING ·Phase: NA
-
A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma
NCT00001271 ·Status: COMPLETED ·Phase: PHASE1
-
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
NCT00058773 ·Status: TERMINATED ·Phase: PHASE1
-
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
NCT01490801 ·Status: COMPLETED
-
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
NCT07162012 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
NCT00307710 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)
NCT00368082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
NCT04566978 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001301 ·Status: COMPLETED
-
S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone
NCT00933127 ·Status: COMPLETED
-
A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
NCT05343377 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma
NCT04434833 ·Status: UNKNOWN
-
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
NCT02108444 ·Status: COMPLETED
-
Frontline of ASCT in High-risk DLBCL
NCT05831865 ·Status: RECRUITING
-
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
NCT00900250 ·Status: COMPLETED
-
Cell Free DNA in Mature B-cell Lymphoma
NCT04088422 ·Status: RECRUITING
-
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT02856646 ·Status: COMPLETED
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
NCT00867087 ·Status: COMPLETED ·Phase: PHASE2